Cécile Chartier
Director/Board Member at CELLECTIS S.A.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Sourdive | M | 57 | 25 years | |
| André Choulika | M | 59 | 25 years | |
| Marie-Bleuenn Terrier | F | 42 | 16 years | |
| Adam Margolin | M | - |
NextVivo, Inc.
 NextVivo, Inc. Packaged SoftwareTechnology Services NextVivo, Inc. is a biotech company based in California that is focused on developing an immune organoid technology platform to accelerate the development of safer and more effective therapies. The American company's mission is to generate and test immune-competent human-derived models that can be used to develop cell and antibody therapies and test immune-modulating drug candidates for a range of diseases, including cancer, infection, and autoimmune disorders. The company was co-founded by Dr. Mark Davis and Dr. Calvin Kuo from Stanford University, and by Dr. Adam Margolin, former chair and professor of genetics and genomic science and senior associate dean. Dr. Adam Margolin has been the CEO since incorporation. | - |
| Laurent Arthaud | M | 61 | 13 years | |
| Pierre Bastid | M | 69 | 13 years | |
| Axel-Sven Malkomes | M | 57 | 2 years | |
| Stephan Reynier | M | 55 | 13 years | |
| Donald Bergstrom | M | 52 | 2 years | |
| Rainer Boehm | M | 63 | 7 years | |
| Mark Frattini | M | 58 | 4 years | |
| Diana Symmes | F | - |
NextVivo, Inc.
NextVivo, Inc. Packaged SoftwareTechnology Services NextVivo, Inc. is a biotech company based in California that is focused on developing an immune organoid technology platform to accelerate the development of safer and more effective therapies. The American company's mission is to generate and test immune-competent human-derived models that can be used to develop cell and antibody therapies and test immune-modulating drug candidates for a range of diseases, including cancer, infection, and autoimmune disorders. The company was co-founded by Dr. Mark Davis and Dr. Calvin Kuo from Stanford University, and by Dr. Adam Margolin, former chair and professor of genetics and genomic science and senior associate dean. Dr. Adam Margolin has been the CEO since incorporation. | - |
| Arthur Stril | M | 35 | 6 years | |
| Jean-Pierre Garnier | M | 75 | 4 years | |
| Kyung Nam-Wortman | F | 54 | 4 years | |
| Steve Doares | M | - | 4 years | |
| Philippe Duchateau | M | 61 | 23 years | |
| Pascalyne Wilson | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Annick Schwebig | M | 73 | 12 years | |
| Herve Hoppenot | M | 64 | 6 years | |
| Bing Wang | M | 47 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 19 | 90.48% |
| United States | 2 | 9.52% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Cécile Chartier
- Personal Network
